Terry Horton

Bringing Buprenorphine‐Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field Experience

Leslie Amass, Walter Ling, Thomas E. Freese et al. · American Journal on Addictions · 2004 · 148 citations · Full text

Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community

Frances R. Levin, Suzette M. Evans, Suzanne K. Vosburg et al. · Addictive Behaviors · 2004 · 119 citations

Substance Abuse, Substance Use, Psychiatry +13

Can Substance Use Disorders be Managed Using the Chronic Care Model? Review and Recommendations from a NIDA Consensus Group

A. Thomas McLellan, Joanna L. Starrels, Betty Tai et al. · Public health reviews · 2013 · 98 citations · Full text

Substance Use, Chronic Illnesses, Drug Treatment +19

Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine–naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence

Douglas Ziedonis, Leslie Amass, Marc L. Steinberg et al. · Drug and Alcohol Dependence · 2008 · 64 citations · Full text

Opioid Epidemic, Substance Abuse, Substance Use +11

Alcohol Withdrawal Rates in Hospitalized Patients During the COVID-19 Pandemic

Ram A. Sharma, Keshab Subedi, Bayo Gbadebo et al. · JAMA Network Open · 2021 · 51 citations · Full text